GALLANT 8 Tesaglitazar Add-on to Metformin

NCT00251953 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

555

Enrollment

INDUSTRY

Sponsor class

Stopped The development program has been terminated

Conditions

Type 2 Diabetes

Interventions

DRUG: Tesaglitazar
DRUG: Metformin

Sponsor

AstraZeneca